companydata.dkcompanydata.dk

EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2024

CVR: 32770487

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -24,035,211 and a net result of DKK -19,830,535 compared with DKK -55,629,460 the year before. Equity in the 2024 report amounted to DKK 32,798,390. The solvency ratio was 56.6%. The company had 17 employees in the financial year.

Gross Profit
DKK -24,035,211
Profit/Loss
DKK -19,830,535
Equity
DKK 32,798,390
Total Assets
DKK 57,973,751
Employees
17

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--24M-19.8M32.8M17
2023--38.9M-55.6M41.9M26
2022--57.9M-79.1M68.5M27
2021--7.8M-27.2M97.3M21
2020--7M-18.4M64.3M16

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

EXPRES2ION BIOTECHNOLOGIES ApS: The 2023 annual report is outJun 12, 2024

EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2023. Gross profit came to DKK -38,920,365, and the net result was DKK -55,629,460.

About EXPRES2ION BIOTECHNOLOGIES ApS

EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.

Source: annual report 2025, Danish Business Authority